The Centers for Medicare and Medicaid Services has withdrawn prohibitions barring manufacturers from publicly disclosing aspects of the Medicare drug price negotiation process in its final guidance on the first round of negotiations, released on 30 June.
The guidance is an important milestone in the implementation of the price negotiation program, which will begin this fall for...







